au.\*:("PETO R")
Results 1 to 25 of 124
Selection :
MYELOMA AND LEUKAEMIA TRIALS = LES ESSAIS DANS LES MYELOMES ET LES LEUCEMIESPETO R.sdPROC. R. SOC. MED.; G.B.; DA. 197; VOL. 65; NO 3; PP. 244-245; BIBL. 1REF.Serial Issue
RANK TESTS OF MAXIMAL POWER AGAINST LEHMANN-TYPE ALTERNATIVESPETO R.1972; BIOMETRIKA; G.B.; DA. 1972; VOL. 59; NO 2; PP. 472-475; BIBL. 2 REF.Serial Issue
CIGARETTE SMOKING AND BRONCHIAL CARCINOMA: DOSE AND TIME RELATIONSHIPS AMONG REGULAR SMOKERS AND LIFELONG NONSMOKERSDOLL R; PETO R.1978; J. EPIDEMIOL. COMMUN. HEALTH; GBR; DA. 1978; VOL. 32; NO 4; PP. 303-313; BIBL. 10 REF.Article
Prospectives de la mortalitéPETO, R.Première conférence européenne sur les politiques antitabac. 1988, 22 p.Conference Proceedings
THE CAUSES OF CANCER: QUANTITATIVE STIMATES OF AVOIDABLE RISKS OF CANCER IN THE UNITED STATES TODAYDOLL R; PETO R.1981; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1981; VOL. 66; NO 6; PP. 1191-1308; BIBL. 6 P.Article
MORTALITY IN RELATION TO SMOKING: 20 YEARS'OBSERVATIONS ON MALE BRITISH DOCTORS.DOLL R; PETO R.1976; BRIT. MED. J.; G.B.; DA. 1976; NO 6051; PP. 1525-1536; BIBL. 49 REF.Article
Smoking and death : the past 40 years and the next 40PETO, R.BMJ. British medical journal (International ed.). 1994, Vol 309, Num 6959, pp 937-939, issn 0959-8146Article
The avoidance of premature death = Eviter les morts prématuréesPETO, R.Tobacco priorities & strategies. 1989, non paginé 2 pConference Proceedings
L'HISTOIRE NATURELLE DE L'OBSTRUCTION CHRONIQUE DES VOIES AERIENNESFLETCHER C; PETO R.1978; BULL. UN. INTERNATION. TUBERC.; FRA; DA. 1978; VOL. 53; NO 2; PP. 79-87; BIBL. 32 REF.Article
THE NATURAL HISTORY OF CHRONIC AIRFLOW OBSTRUCTION.FLETCHER C; PETO R.1977; BRIT. MED. J.; G.B.; DA. 1977; NO 6077; PP. 1645-1648; BIBL. 32 REF.Article
UNCERTAINTY ESTIMATES FOR LOW-DOSE-RATE EXTRAPOLATIONS OF ANIMAL CARCINOGENICITY DATA.GUESS H; CRUMP K; PETO R et al.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 10; PP. 3475-3483; BIBL. 21 REF.Article
CONTROLLED TRIAL OF REPEATED HALOTHANE ANAESTHETICS IN PATIENTS WITH CARCINOMA OF THE UTERINE CERVIX TREATED WITH RADIUM = CONTROLE DES ANESTHESIES REPETEES A L'HALOTHANE CHEZ DES MALADES ATTEINTES DE CANCER DU COL UTERIN, TRAITE PAR LE RADIUMTROWELL J; PETO R; SMITH AC et al.1975; LANCET; G.B.; DA. 1975; NO 7911; PP. 821-824; BIBL. 9REF.Article
STATISTICAL ANALYSIS OF THE BIOASSAY OF CONTINUOUS CARCINOGENS = ANALYSE STATISTIQUE DU DOSAGE BIOLOGIQUE DES CANCERIGENES EN ADMINISTRATION CONTINUEPETO R; LEE PN; PAIGE WS et al.1972; BRIT. J. CANCER; G.B.; DA. 1972; VOL. 26; NO 4; PP. 258-261; BIBL. 10REF.Serial Issue
INITIATION AND PROMOTION AT DIFFERENT AGES AND DOSES IN 2200 MICE. III: LINEAR EXTRAPOLATION FROM HIGH DOSES MAY UNDERESTIMATE LOW-DOSE TUMOUR RISKSSTENBACK F; PETO R; SHUBIK P et al.1981; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1981; VOL. 44; NO 1; PP. 24-34; BIBL. 18 REF.Article
RENAL PROSTAGLANDIN SYNTHESIS IN THE GOLDBLATT HYPERTENSIVE RAT = SYNTHESE RENALE DE PROSTAGLANDINE CHEZ LE RAT AVEC HYPERTENSION ARTERIELLE TYPE GOLDBLATTPUGSLEY DJ; BEILIN LJ; PETO R et al.1975; CIRCUL. RES., SUPPL.; U.S.A.; DA. 1975; VOL. 36; NO 1; PP. 81-88; BIBL. 1 P. 1/2Article
RENAL PROSTAGLANDIN SYNTHESIS IN EXPERIMENTAL RENAL CLIP HYPERTENSION IN THE RATPUGSLEY D; BEILIN L; PETO R et al.1976; ADV. PROSTAGLANDIN THROMBOXANE RES.; U.S.A.; DA. 1976; VOL. 2; PP. 595-598; BIBL. 5 REF.; (INT. CONF. PROSTAGLANDINS PROC.; FLORENCE; 1975)Conference Paper
INITIATION AND PROMOTION AT DIFFERENT AGES AND DOSES IN 2200 MICE. I: METHODS, AND THE APPARENT PERSISTENCE OF INITIATED CELLSSTENBACK F; PETO R; SHUBIK P et al.1981; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1981; VOL. 44; NO 1; PP. 1-14; BIBL. 25 REF.Article
INITIATION AND PROMOTION AT DIFFERENT AGES AND DOSES IN 2200 MICE. II: DECREASE IN PROMOTION BY TPA WITH AGEINGSTENBACK F; PETO R; SHUBIK P et al.1981; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1981; VOL. 44; NO 1; PP. 15-23; BIBL. 10 REF.Article
Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomised trials among 28,696 womenPETO, R.Hormone research. 1989, Vol 32, Num S1, issn 0301-0163, p. 165Conference Paper
FUNDAMENTAL CARCINOGENIC PROCESSES AND THEIR IMPLICATIONS FOR LOW DOSE RISK ASSESSMENT.CRUMP KS; HOEL DG; LANGLEY CH et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 9 PART. 1; PP. 2973-2979; BIBL. 16 REF.Article
MATERNAL SERUM ALPHA-FETOPROTEIN AND PREVIOUS NEURAL TUBE DEFECTS.WALD N; BARKER S; PETO R et al.1976; BRIT. J. OBSTETR. GYNAECOL.; G.B.; DA. 1976; VOL. 83; NO 3; PP. 213-216; BIBL. 7 REF.Article
A LONG-TERM FOLLOW- UP STUDY OF WOMEN USING DIFFERENT METHODS OF CONTRACEPTION: AN INTERIM REPORT.VESSEY M; DOLL R; PETO R et al.1976; J. BIOSOC. SCI.; G.B.; DA. 1976; VOL. 8; NO 4; PP. 373-427Article
Risk factors for coronary heart disease and infection with Helicobacter pylori : Meta-analysis of 18 studiesDANESH, J; PETO, R.BMJ. British medical journal (International ed.). 1998, Vol 316, Num 7138, pp 1130-1132, issn 0959-8146Article
MORTALITY IN RELATION TO SMOKING: 22 YEARS' OBSERVATIONS ON FEMALE BRITISH DOCTORSDOLL R; GRAY R; HAFNER B et al.1980; BRIT. MED. J.; GBR; DA. 1980; NO 6219; PP. 967-971; BIBL. 20 REF.Article
MATERNAL SERUM ALPHA -FETOPROTEIN LEVELS IN MULTIPLE PREGNANCY = TAUX SERIQUE DES ALPHA FOETO PROTEINES DE LA MERE DANS LES GROSSESSES MULTIPLESWALD N; BARKER S; PETO R et al.1975; BRIT. MED. J.; G.B.; DA. 1975; NO 5959; PP. 651-652; BIBL. 8 REF.Article